This statistic shows the number of new drugs in research and development (R&D) pipelines of major South Korean pharmaceutical companies in 2014, by therapeutic area. In that year there were 41 new anti-cancer drugs in the R&D pipelines of major Korean pharmaceutical companies.
New drugs in R&D pipelines of major pharmaceutical companies in South Korea in 2014, by therapeutic category
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic R&D expenditure of new therapeutic drugs 2009-2018
- Basic Statistic Share of recruiting clinical studies worldwide by location 2024
- Basic Statistic Percent of registered clinical studies worldwide by type 2024
- Basic Statistic Price disparities for top product Advair Diskus U.S. vs international 2024
- Basic Statistic Price disparities for top product Xarelto - U.S. and international 2024
- Premium Statistic Price disparities for top product Januvia U.S. vs international 2024
- Basic Statistic Price disparities for Spiriva Handihaler - U.S. and international 2024
- Basic Statistic Price disparities for top product Symbicort - U.S. and international 2024
- Basic Statistic Price disparities for top product Viagra - U.S. and international 2024
- Basic Statistic Drug cost distribution by drug type in public drug plans Canada 2021/2022
About the region
10
- Premium Statistic Number of new pharmaceutical drug approvals in South Korea 2014 by therapeutic area
- Basic Statistic Number of clinical trials for new drugs in South Korea 2010-2020
- Premium Statistic OTC drug products production value South Korea 2012-2022
- Premium Statistic Leading pharmaceutical companies South Korea 2022, by production value
- Premium Statistic Leading pharmaceutical products South Korea 2022, by production value
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2022, by export value
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2022, by import value
- Premium Statistic Number of employees in the South Korean pharmaceutical industry 2019, by sector
- Premium Statistic Number of pharmaceutical distributors South Korea 2022, by type
- Premium Statistic Number of pharmaceutical manufacturers South Korea 2012-2022
Selected statistics
6
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
Other regions
10
- Premium Statistic Research & development spending on drug development in the U.S. 2022
- Basic Statistic Distribution pharmacy revenues in Denmark by product type 2022
- Basic Statistic Spending on R&D from pharmaceutical industry in Canada 2004-2022
- Basic Statistic Eli Lilly's research and development expenditure 2007-2023
- Basic Statistic Expenditure on prescription pharmaceuticals in Sweden 2009-2022
- Premium Statistic LabCorp revenues 2013-2023
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Premium Statistic Venezuela: pharma industry market value 2008-2017
- Basic Statistic Antidepressants pharmaceutical consumption in the Netherlands 2007-2021
- Basic Statistic Antidepressants pharmaceutical daily consumption in Germany 2007-2021
Related statistics
10
- Premium Statistic Prescription drug products production value South Korea 2012-2022
- Basic Statistic Pharmaceutical production value South Korea 2012-2022
- Premium Statistic Number of pharmaceutical distributors South Korea 2012-2022
- Premium Statistic Therapeutic sectors for drug products South Korea 2019, by production value
- Premium Statistic Pharmaceuticals market size South Korea 2012-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Johnson & Johnson's number of employees 2004-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Johnson & Johnson's number of employees 2004-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
Korea Drug Research Association. (July 16, 2016). New drugs in R&D pipelines of major pharmaceutical companies in South Korea in 2014, by therapeutic category [Graph]. In Statista. Retrieved April 25, 2024, from https://www.statista.com/statistics/646580/new-drugs-research-and-development-pipelines-south-korea-by-category/
Korea Drug Research Association. "New drugs in R&D pipelines of major pharmaceutical companies in South Korea in 2014, by therapeutic category ." Chart. July 16, 2016. Statista. Accessed April 25, 2024. https://www.statista.com/statistics/646580/new-drugs-research-and-development-pipelines-south-korea-by-category/
Korea Drug Research Association. (2016). New drugs in R&D pipelines of major pharmaceutical companies in South Korea in 2014, by therapeutic category . Statista. Statista Inc.. Accessed: April 25, 2024. https://www.statista.com/statistics/646580/new-drugs-research-and-development-pipelines-south-korea-by-category/
Korea Drug Research Association. "New Drugs in R&d Pipelines of Major Pharmaceutical Companies in South Korea in 2014, by Therapeutic Category ." Statista, Statista Inc., 16 Jul 2016, https://www.statista.com/statistics/646580/new-drugs-research-and-development-pipelines-south-korea-by-category/
Korea Drug Research Association, New drugs in R&D pipelines of major pharmaceutical companies in South Korea in 2014, by therapeutic category Statista, https://www.statista.com/statistics/646580/new-drugs-research-and-development-pipelines-south-korea-by-category/ (last visited April 25, 2024)
New drugs in R&D pipelines of major pharmaceutical companies in South Korea in 2014, by therapeutic category [Graph], Korea Drug Research Association, July 16, 2016. [Online]. Available: https://www.statista.com/statistics/646580/new-drugs-research-and-development-pipelines-south-korea-by-category/